Jones Financial Companies
PACB icon

Jones Financial Companies’s Pacific Biosciences PACB Stock Holding History

Jones Financial Companies’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Hold
1,000
– – ﹤0.01% 4485
2026
Q1 		$1.26K Sell
1,000
-1,666
-62% -$2.98K ﹤0.01% 4290
2025
Q4 		$4.99K Buy
+2,666
New +$5.12K ﹤0.01% 3502

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jones Financial Companies's PACB Position: Q2 2026 in Review

Jones Financial Companies held its Pacific Biosciences (PACB) position steady in Q2 2026 at 1,000 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4485.

Jones Financial Companies first reported a position in PACB in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.99K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Jones Financial Companies held 1,000 shares of Pacific Biosciences worth $1.65K as of Q2 2026.
  • Jones Financial Companies left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4485 holding.
  • Jones Financial Companies first reported a position in Pacific Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Pacific Biosciences position peaked at $4.99K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.